1[1]Jens K,Moller,Mogens K.Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in chroriic pe1vic inf1aminatorydisease.International Journal of Infectious Diseases,2006,9(5):263.
3[3]Helio SS,Ronald NJ.Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.International Journal of Antimicrobial Agents,2007,25(5):308.
4Pimenta JM, Catchpole M, Roger PA, et al. Opportunistic screening for genital chlamydial infection. Ⅱ: prevalence among healthcare attenders, outcome, and evaluation of positive cases[J].Sex Transm Infect, 2003,79 ( 1 ): 22-27.
5Low N, Egger M.What should we cio about screening for genital chlamydia[J] ?Int J Epidemiol, 2002,31 (5): 891-893.
6Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The azithromycin for chlamydial infections study group. N Engl J Med, 1992, 327(13): 921 -925.
7Charoenwatanachokchai A, Chitwarkorn A, Palanuvej T, et al.Azithromycin in non- gonococcal urethritis. J Med Assoc Thai,1997, 80(7): 440 - 445.
8Peters DH; Friedel HA; McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs, 1992, 44(5) :750 - 799.
